Inactive Instrument
Sector Ariad Pharmaceuticals, Inc.
Stocks
US04033A1007
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 17-01-10 | Takeda Pharmaceutical : Japan's Takeda ready for fresh acquisitions after $5.2 billion Ariad deal | RE |
| 14-06-02 | Dai ichi Life Insurance : U.S. futures flat with Dow, S&P at record levels | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | - | - | - | - | - | 0 | |
| -2.01% | -7.86% | +1.94% | +28.23% | +70.10% | +54.60% | +70.97% | +3.48% | - | 70.44B | |
| +3.84% | -11.02% | -14.01% | -1.97% | +4.10% | +8.59% | +58.77% | +188.00% | +4,911.42% | 50.31B | |
| +3.35% | +1.42% | +9.58% | +0.52% | +8.85% | +11.85% | +37.39% | -18.60% | +221.65% | 47.51B | |
| +0.78% | +1.41% | -1.48% | +25.94% | +16.12% | +27.83% | +31.54% | +6.05% | +247.42% | 42.91B | |
| +2.16% | -3.84% | -5.83% | +4.42% | +142.50% | +306.63% | +466.09% | +571.13% | - | 40.39B | |
| +1.24% | -3.03% | -0.24% | +15.15% | +16.19% | +9.99% | +102.94% | -0.69% | +1,019.89% | 39.69B | |
| +0.06% | -1.43% | +0.90% | +2.68% | +4.30% | +10.47% | +43.27% | +1.48% | +150.60% | 30.59B | |
| -2.95% | -14.09% | +5.83% | +33.28% | +58.21% | +37.94% | +1.30% | -54.11% | - | 26.8B | |
| +0.23% | -6.38% | -9.80% | -1.36% | -6.33% | -13.10% | -8.04% | -64.38% | - | 22.36B | |
| +0.45% | -0.24% | +17.25% | +33.39% | +22.40% | +18.99% | +10.27% | -11.46% | +120.93% | 22.1B | |
| +0.80% | -4.50% | -22.46% | -11.76% | -44.17% | -39.79% | +287.40% | +261.19% | +607.13% | 21.14B | |
| +1.40% | +2.14% | +3.65% | +15.11% | +9.89% | +19.39% | +160.11% | +230.73% | +2,013.60% | 17.02B | |
| +2.15% | +1.28% | -7.03% | -4.80% | +180.86% | +152.40% | +365.04% | +1,842.82% | +746.76% | 15B | |
| -0.76% | +1.75% | +7.90% | +12.84% | +24.78% | +25.54% | +54.48% | -29.32% | +86.31% | 15.25B | |
| +1.53% | -0.74% | -14.42% | -14.63% | - | - | - | - | - | 14.66B | |
| +2.55% | +4.13% | +8.26% | +9.12% | +38.84% | +54.02% | +182.13% | +178.64% | +437.59% | 14.75B | |
| +1.50% | +0.70% | +10.73% | +30.80% | +51.60% | +77.76% | +56.90% | -25.48% | +275.44% | 14.27B | |
| -2.84% | -8.54% | -6.02% | -13.25% | +11.47% | -11.64% | +428.02% | - | - | 13.7B | |
| -2.42% | -16.07% | -18.21% | -2.62% | -13.87% | -30.74% | +760.86% | +185.32% | +40.66% | 12.41B | |
| Average | +0.60% | -3.90% | -1.76% | +8.48% | +33.10% | +40.04% | +172.75% | +192.05% | +836.88% | 26.57B | |
| Weighted average by Cap. | +0.75% | -4.50% | -1.35% | +10.85% | +35.46% | +46.08% | +134.16% | +139.64% | +1,127.00% |
- Stock Market
- Stocks
- Stock
- Sector Ariad Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
